Home care management of patients affected by hematologic malignancies: A review

Haematologica

Volumn 91, Issue 11, 2006, Pages 1523-1529

  Niscola, Pasquale ^a   De Fabritiis, Paolo ^a   Cartoni, Claudio ^b   Romani, Claudio ^c   Sorrentino, Francesco ^a   Dentamaro, Teresa ^a   Piccioni, Daniela ^a   Scaramucci, Laura ^a   Giovannini, Marco ^d   Amadori, Sergio ^a   Mandelli, Franco ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Ospedale Oncologico A Businco   (Italy)

^d Umberto I Hospital   (Italy)

Author keywords

Early discharge; Hematologic malignancies; Hematopoietic stem cell transplantation (HSCT); Home care; Managed care; Palliative care

Indexed keywords

ANEMIA; ARTICLE; BLEEDING; BUDGET; CANCER PAIN; CANCER REGRESSION; CAREGIVER; DISEASE COURSE; ECONOMIC ASPECT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOME CARE; HOSPITALIZATION; HUMAN; INFECTION; PALLIATIVE THERAPY; PATIENT CARE; QUALITY OF LIFE; RISK ASSESSMENT; TERMINAL DISEASE;

EID: 33750935617     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. Niscola P, Cartoni C, Moleti ML, Brunetti G, D'Elia GM, Giovannini M, et al. Home care in hematology. Acta Med Rom 2000;38:338-44.
2. Alban-Jones C, Moth L. Home care for terminally ill haematology patients. In: Both S, Bruera S. Palliative care Consultation Haematology. Oxford University Press, New York. 2003. P. 219-35.
3. Newton S. Haematology and palliative care: blood, sweat and tears. Intern Med J 2003;33:549-51.
4. Randall F. Terminal care in haematology. Baillieres Clin Haematol 1987;1:581-91.
5. Niscola P, Scaramucci L, Giovannini M Anghel G, Romani C, Palombi F, et al. Palliative Care in malignant hematology: an overview. Haema 2005;8:297-315.
6. Casini C, Carrai V, Innocenti F, Teodori P, Rigacci L, Rossi Ferrini P. Hematological Home Care (HCC): ten years activity. (Abstract 249). Abstract book of the seventh annual meeting of the European Haematology Association. Florence (Italy), 2002. The Haematology Journal vol. 3 Suppl 1:84.
7. Cartoni C, Brunetti GA, D'Elia GM, Breccia M, Moleti ML, Mandelli F. Home care for patients with hematologic malignancies. (Abstract 254). Abstract book of the seventh annual meeting of the European Haematology Association. Florence (Italy), 2002. The Haematology Journal vol. 3 Suppl 1:84.
8. Miano M, Manfredini L, Garaventa A, Fieramosca S, Tanasini R, Leimer M, et al. Feasibility of a home care program in a pediatric hematology and oncology department. Results of the first year of activity at a single Institution. Haematologica 2002;87:637-42.
9. Stevens B, McKeever P, Law MP, Booth M, Greenberg M, Daub S, et al. Children receiving chemotherapy at home: perceptions of children and parents. J Pediatr Oncol Nurs 2006;23:276-85.
10. Smith AG, Soutar RL, Schey S, Andrews CD, Baister ER, Bilbrough C, et al. Home care versus hospital care in patients with multiple myeloma treated with pamidronate. Int J Palliat Nurs. 2004;10:144-9.
11. Lowenthal RM, Piaszczyk A, Arthur GE, O'Malley S. Home chemotherapy for cancer patients: cost analysis and safety. Med J Aust 1996;165:184-7.
12. Craig JI, Milligan P, Cairns J, McClelland DB, Parker AC. Nurse practitioner support for transfusion in patients with haematological disorders in hospital and at home. Transfus Med 1999;9:31-6.
13. Coyte PC, Dobrow MJ, Broadfield L. Incremental cost analysis of ambulatory clinic and home-based intravenous therapy for patients with multiple myeloma. Pharmacoeconomics 2001;19:845-54.
14. Chern B, Joseph D, Joshua D, Pittman K, Richardson G, Schou M, et al. Bisphosphonate infusions: patient preference, safety and clinic use. Support Care Cancer 2004;12:463-6.
15. Stevens B, Croxford R, McKeever P, Yamada J, Booth M, Daub S, et al. Hospital and home chemotherapy for children with leukemia: a randomized cross-over study. Pediatr Blood Cancer 2006;47:285-92.
16. Russell JA, Poon MC, Jones AR, Woodman RC, Ruether BA. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 1992;339:38-40.
17. Westermann AM, Holtkamp MM, Linthorst GA, van Leeuwen L, Willemse EJ, van Dijk WC, et al. At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Ann Oncol 1999;10:511-7.
18. Herrmann RP, Trent M, Cooney J, Cannell PK. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 1999;24:1213-7.
19. Russell JA, Chaudhry A, Booth K, Brown C, Woodman RC, Valentine K, et al. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience. Biol Bone Marrow Transplant 2000;6:109-14.
20. Svahn BM, Bjurman B, Myrback KE, Aschan J, Ringden O. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant 2000;26:1057-60.
21. Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P, et al. O. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002;100:4317-24.
22. Cartoni C, Cedrone M, De Gregoris C, Giovannini M, Niscola P, Romani C, et al. Early discharge and home care management of therapy-induced neutropenic AML patients. (Abstract n. P-0893). Br J Haematol Vol. 102, No 1:224.
23. Miano M, Manfredini L, Garaventa A, Fieramosca S, Tanasini R, Morreale G, et al. Home care for children following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003;31:607-10.
24. Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994;12:107-14.
25. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
26. Santolaya ME, Alvarez AM, Aviles CL, Becker A, Cofre J, Cumsille MA, et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 2004;22:3784-9.
27. Svahn BM, Ringden O, Remberger M. Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2005;36:511-6.
28. van Tiel FH, Harbers MM, Kessels AG, Schouten HC. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol 2005;16:195-205.
29. Lassauniere JM, Zittoun R. The Palliative Care Centre of Hotel-Dieu Hospital. Support Care Cancer 1995;3:7-10.
30. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003;98:1786-801.
31. Birgegard G, Aapro MS, Bokemeyer C, Dicato M, Drings P, Homedo J, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 2005;68Suppl 1:3-11.
32. Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk Res 2003;27:481-8.
33. Gedaly-Duff V, Lee KA, Nail L, Nicholson HS, Johnson KP. Pain, sleep disturbance, and fatigue in children with leukemia and their parents: a pilot study. Oncol Nurs Forum 2006;33:641-6.
34. Niscola P, Arcuri E, Giovannini M, Scaramucci L, Palombi F, Trapè G, et al. Pain syndromes in haematological malignancies: an overview. Hematol J 2004;5:293-303.
35. Niscola P, Cartoni C, Arcuri E, Giovannini M, Romani C, Leonetti Crescenzi S, et al. Epidemiologia e fisiopatogenesi del dolore nelle neoplasie ematologiche in fase avanzata. La Rivista Italiana di Cure Palliative 2000;3:157-61.
36. Girmenia C, Moleti ML, Cartoni, Cedrone M, De Gregoris C, De Sanctis V, et al. management of infective complications in patients with advanced haematologic malignancies in home care. Leukaemia 1997;11:1807-12.
37. Avvisati G, Tirindelli MC, Annibali O. Thrombocytopenia and hemorrhagic risk in cancer patients. Crit Rev Oncol Hematol 2003;48 Suppl:S13-6.
38. Cartoni C, Cedrone M, De Gregoris C, Giovannini M, Niscola P, Romani C, et al. Domiciliary management of hemorrhage for patients with advanced-phase hematologic neoplasm. (Abstr 1345). Abstract book of the ISH - EHA Combined Haematology Congress, Amsterdam, The Netherlands, 4-8 July 1998. Br J Haematol 1998;102:337.
39. Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000;342:326-33.
40. Bauduer F, Capdupuy C, Renoux M. Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support Care Cancer 2000;8:302-6.
41. Fallon M. Care of the terminally ill cancer patient: a handbook for the medical oncologist. Br J Cancer 2004;90:22-47.
42. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl J Med 2004;350:2582-90.
43. Rushton CH. A framework for integrated pediatric palliative care: being with dying. J Pediatr Nurs 2005;20:311-25.
44. Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life. Leuk Res 2001;25:673-80.
45. Surbone A. There is no dividing line. Crit Rev Oncol Hematol 2003;46:1-3.
46. Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 2000;3:287-300.
47. Maddocks I, Bentley L, Sheedy J. Quality of life issues in patients dying from haematological diseases. Ann Acad Med Singapore 1994;23:244-8.
48. Finlay IG, Higginson IJ, Goodwin DM, Cook AM, Edwards AG, Hood K, et al. Palliative care in hospital, hospice, at home: results from a systematic review. Ann Oncol 2002;13 Suppl 4:257-64.
49. Giovannini M, Cartoni C, Cedrone M, De Gregoris C, Discola P, Romani C, et al. Chemioterapia palliativa in pazienti con neoplasie ematologiche in fase avanzata di malattia: esperienza dell'Unità di Cure domiciliari "Romail" presso l'Istituto d'Ematologia dell'Universita "La Sapienza" di Roma. Paper presented at the eighth Congress of the Società Italiana di Cure Palliative, Genoa, 1997.
50. Funke I, Wiesneth M, Platow S, Kubanek B. Palliative cytoreduction in refractory acute leukemia: a retrospective study of 57 adult patients. Ann Hematol 2000;79:132-7.
51. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage 2004;28:548-56.
52. No author listed. Symptom relief in terminal illness. WHO; Geneva: Switzerland. 1998.
53. Muirhead CS, Erskine G, McColl M, Eynaud P, Tadjali M. Haematology and palliative care: an integrated approach. Abstract book of the tenth annual meeting of the European Haematology Association. Stockholm (Sweden), 2005. Haematologica/The Haematology J vol. 90 Suppl 2:111[Abstract 279].
54. Meier DE, Thar W, Jordan A, Goldhirsch SL, Siu A, Morrison RS. Integrating case management and palliative care. J Palliat Med 2004;7:119-34.
55. Hinton J. Which patients with terminal cancer are admitted from home care? Palliat Med 1994;8:197-210.
56. Romani C, Cartoni C, Cedrone M, De Gregoris C, Giovannini M, Niscola P, et al. Il Ricovero Ospedaliero nei pazienti affetti da emopatie neoplastiche in fase avanzata seguiti in regime di assistenza domiciliare. Paper presented at the eighth Congress of the Società Italiana di Cure Palliative, Genoa, 1997.
57. Smeenk FW, van Haastregt JC, de Witte LP, Crebolder HF. Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review. Br Med J 1998;316:1939-44.
58. Costantini M, Higginson IJ, Boni L, Orengo MA, Garrone E, Henriquet F, Bruzzi P. Effect of a palliative home care team on hospital admissions among patients with advanced cancer. Palliat Med 2003;17:315-21.
59. Tanneberger S, Pannuti F, Mirri R, Panetta A, Mariano P, Romano D et al. Hospital-at-Home for advanced cancer patients within the framework of the Bologna Eubiosia project: an evaluation. Tumori 1998;84:376-82.
60. Ahmedzai SH, Costa A, Blengini C, Bosch A, Sanz-Ortiz J, Ventafridda V, et al. A new international framework for palliative care. Eur J Cancer 2004;40:2192-200.
61. Carson MG, Fitch MI, Vachon ML. Measuring patient outcomes in palliative care: a reliability and validity study of the Support Team Assessment Schedule. Palliat Med 2000;14:25-36.
62. Smeenk FW, de Witte LP, Nooyen IW, Crebolder HF. Effects of transmural care on coordination and continuity of care. Patient Educ Couns 2000;41:73-81.
63. Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291:88-93.
64. Street AF, Love A, Blackford J. Managing family centered palliative care in aged and acute settings. Nurs Health Sci 2005;7:45-55.
65. McGrath P. Caregivers' insights on the dying trajectory in hematology oncology. Cancer Nurs 2001;24:413-21.
66. Abrahm JL. Waiting for the platelet count to rise: negotiating care at the end of life. Cancer Invest 2003;21:772-81.
67. Aldo L, Levaggi R. Assistenza domiciliare nelle cure palliative. I costi della comunicazione. La Rivista Italiana di Cure Palliative (RICP). n. 3/4:26-30, 2004.
68. Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL. Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers. Ann Intern Med 2000;132:451-9.
69. Emanuel EJ, Ash A, Yu W, Gazelle G, Levinsky NG, Saynina O, et al. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med 2002;162:1722-8.
70. Andrews F, Hood P. Shared care: hospital, hospice, home. Paediatr Nurs. 2003;15:20-2.
71. Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. Br Med J 2005;330:1007-11.
72. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003;289:2387-92.
73. Goodwin DM, Higginson IJ, Myers K, Douglas HR, Normand CE. Effectiveness of palliative day care in improving pain, symptom control, and quality of life. J Pain Symptom Manage 2003;25:202-12.
74. Travis SS, Moore S, Larsen PD, Turner M. Clinical indicators of treatment futility and imminent terminal decline as discussed by multidisciplinary teams in long-term care. Am J Hosp Palliat Care 2005;22:204-10.
75. Boyce A, McHugh M, Lyon P. Proactive palliative care choices for haematology day unit patients. Int J Palliat Nurs 2003;9:544-50.
76. Wrede-Seaman LD. Management of emergent conditions in palliative care. Prim Care 2001;28:317-28.
77. Lassauniere JM, Bertolino M, Hunault M, Zittoun R, Verspieren P, Moh-Klaren J, et al. Platelet transfusions in advanced hematological malignancies: a position paper. J Palliat Care 1996;12:38-41.
78. Brook L, Vickers J, Pizer B. Home platelet transfusion in pediatric oncology terminal care. Med Pediatr Oncol 2003;40:249-51.
79. Prommer E. Management of bleeding in the terminally ill patient. Hematology 2005;10:167-75.
80. Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist 2004;9:561-70.
81. Dunn A, Carter J, Carter H. Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manage 2003;26:1132-9.
82. Niscola P, Scaramucci L, Romani C, Giovannini M, Maurillo L, Del Poeta G, et al. Opioids in pain management of blood-related malignancies. Ann Hematol 2006;85:489-501.
83. Forinder U, Lof C, Winiarski J. Quality of life and health in children following allogeneic SCT. Bone Marrow Transplant 2005;36:171-6.
84. Latagliata R, Alimena G, Carmosino I, Breccia M, Borza PA, Bongarzoni V, et al. Conservative treatment for patients over 80 years with acute myelogenous leukemia. Am J Hematol 2002;71:256-9.
85. Latagliata R, Bongarzoni V, Carmosino I, Mengarelli A, Breccia M, Borza PA, et al. Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon. Ann Oncol 2006;17:281-5.
86. Stalfelt AM. Quality of life of patients with acute myeloid leukaemia. Leuk Res 1994;18:257-67.
87. Corli O, Pizzuto M, Gibellini P. I costi sostenuti dalla famiglia in un programma di cure palliative domiciliari per malati oncologici. La Rivista Italiana di Cure Palliative (RICP). 2002;4:210-12.
88. Yun YH, Rhee YS, Kang IO, Lee JS, Bang SM, Lee WS, et al. Economic burdens and quality of life of family caregivers of cancer patients. Oncology 2005;68:107-14.
89. Cohen SR, Boston P, Mount BM, Porterfield P. Changes in quality of life following admission to palliative care units. Palliat Med 2001;15:363-71.
90. Stromgren AS, Sjogren P, Goldschmidt D, Petersen MA, Pedersen L, Hoermann L, et al. M. A longitudinal study of palliative care: patient-evaluated outcome and impact of attrition. Cancer 2005;103:1747-55.
91. Paci E, Miccinesi G, Toscani F, Tamburini M, Brunelli C, Constantini M, et al. Quality of life assessment and outcome of palliative care. J Pain Symptom Manage 2001;21:179-88.
92. Higginson IJ, Finlay I, Goodwin DM, Cook AM, Hood K, Edwards AG, et al. Do hospital-based palliative teams improve care for patients or families at the end of life? J Pain Symptom Manage 2002;23:96-106.
93. Peters L, Sellick K. Quality of life of cancer patients receiving inpatient and home-based palliative care. J Adv Nurs 2006;53:524-33.
94. Auret K, Bulsara C, Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 2003;33:566-71.
95. McGrath P. Dying in the curative system: the haematology/oncology dilemma. Part 1. Aust J Holist Nurs 2001;8:22-30.
96. McGrath P. End-of-life care for hematological malignancies: the 'technological imperative' and palliative care. Palliat Care 2002;18:39-47.
97. Shepperd S, Iliffe S. The effectiveness of hospital at home compared with inpatient hospital care: a systematic review. J Public Health Med 1998;20:344-50.
98. Ahlner-Elmqvist M, Jordhoy MS, Jannert M, Fayers P, Kaasa S. Place of death: hospital-based advanced home care versus conventional care. A prospective study in palliative cancer care. Palliat Med 2004;18:585-93.
99. Preen DB, Bailey BE, Wright A, Kendall P, Phillips M, Hung J et al. Effects of a multidisciplinary, post-discharge continuance of care intervention on quality of life, discharge satisfaction, and hospital length of stay: a randomized controlled trial. Int J Qual Health Care 2005;17:43-51.
100. McGrath P. Are we making progress? Not in haematology! Omega (Westport) 2002;45:331-48.
101. Monti M, Cunietti E, Castellani L, Merli M, Cruciatti E Ten years' activity of the first Italian public hospice for terminally ill patients. Support Care Cancer 2004;12:752-7.
102. Tang ST. When death is imminent: where terminally ill patients with cancer prefer to die and why. Cancer Nurs 2003;26:245-51.
103. Ahlner-Elmqvist M, Jordhoy MS, Jannert M, Fayers P, Kaasa S. Place of death: hospital-based advanced home care versus conventional care. A prospective study in palliative cancer care. Palliat Med 2004;18:585-93.
104. Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291:88-93.
105. Hayes-Lattin B, Leis JF, Maziarz RT. Isolation in the allogeneic transplant environment: how protective is it? Bone Marrow Transplant 2005;36:373-81.
106. Cartoni C, Brunetti G, D'Elia GM, Morano G, Breccia M, Gentile M, et al. Economic Analysis of a domiciliary program of supportive and palliative care for patients with hematological malignancies. Abstract book of the tenth annual meeting of the European Haematology Association. Stockholm (Sweden), 2005. Haematologica/The Haematology J [Abstract 280] 90 Suppl 2:112.
107. Smeenk FW, Ament AJ, van Haastregt JC, de Witte LP, Crebolder HF. Cost analysis of transmural home care for terminal cancer patients. Patient Educ Couns 1998;35:201-11.
108. McGrath P, Joske D. Palliative care and haematological malignancy: a case study. Aust Health Rev 2002;25:60-6.
109. McGrath P. Qualitative findings on the experience of end-of-life care for haematological malignancies. Am J Hosp Palliat Care 2002;19:103-11.
110. Higginson IJ, Koffman J. Public health and palliative care. Clin Geriatr Med 2005;21:45-55.